Evidence map›Paper›PMID 29643057›Full record

ArticleCirculation2018

Defective Base Excision Repair of Oxidative DNA Damage in Vascular Smooth Muscle Cells Promotes Atherosclerosis.

Aarti Shah, Kelly Gray, Nichola Figg, Alison Finigan, Lakshi Starks, Martin Bennett

Open access · greenAbstract read
In one paragraph

Article in Circulation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. SIRT1: Protean roles at the nexus of health, disease, and therapeutics.Journal of cell communication and signaling · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Aarti ShahDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, United Kingdom. Dr Gray is currently at Cardiovascular Safety, AstraZeneca, Cambridge, United Kingdom.
Kelly GrayDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, United Kingdom. Dr Gray is currently at Cardiovascular Safety, AstraZeneca, Cambridge, United Kingdom.
Nichola FiggDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, United Kingdom. Dr Gray is currently at Cardiovascular Safety, AstraZeneca, Cambridge, United Kingdom.
Alison FiniganDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, United Kingdom. Dr Gray is currently at Cardiovascular Safety, AstraZeneca, Cambridge, United Kingdom.
Lakshi StarksDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, United Kingdom. Dr Gray is currently at Cardiovascular Safety, AstraZeneca, Cambridge, United Kingdom.
Martin BennettDivision of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Centre for Clinical Investigation, Addenbrooke's Hospital, United Kingdom. Dr Gray is currently at Cardiovascular Safety, AstraZeneca, Cambridge, United Kingdom.
Addenbrooke's Hospital · GB

Funding

British Heart Foundation CH/2000003/12800British Heart Foundation PG/11/112/29272British Heart Foundation PG/11/57/29003British Heart Foundation PG/13/25/30014British Heart Foundation PG/16/11/32021British Heart Foundation PG/16/63/32307British Heart Foundation RG/13/14/30314
6 · The paper itself

Abstract

backgroundAtherosclerotic plaques demonstrate extensive accumulation of oxidative DNA damage, predominantly as 8-oxoguanine (8oxoG) lesions. 8oxoG is repaired by base excision repair enzymes; however, the mechanisms regulating 8oxoG accumulation in vascular smooth muscle cells (VSMCs) and its effects on their function and in atherosclerosis are unknown.

methodsWe studied levels of 8oxoG and its regulatory enzymes in human atherosclerosis, the mechanisms regulating 8oxoG repair and the base excision repair enzyme 8oxoG DNA glycosylase I (OGG1) in VSMCs in vitro, and the effects of reducing 8oxoG in VSMCs in atherosclerosis in ApoE

resultsHuman plaque VSMCs showed defective nuclear 8oxoG repair, associated with reduced acetylation of OGG1. OGG1 was a key regulatory enzyme of 8oxoG repair in VSMCs, and its acetylation was crucial to its repair function through regulation of protein stability and expression. p300 and sirtuin 1 were identified as the OGG1 acetyltransferase and deacetylase regulators, respectively, and both proteins interacted with OGG1 and regulated OGG1 acetylation at endogenous levels. However, p300 levels were decreased in human plaque VSMCs and in response to oxidative stress, suggesting that reactive oxygen species-induced regulation of OGG1 acetylation could be caused by reactive oxygen species-induced decrease in p300 expression. We generated mice that express VSMC-restricted OGG1 or an acetylation defective version (SM22α-OGG1 and SM22α-OGG1

conclusionsWe identify defective 8oxoG base excision repair in human atherosclerotic plaque VSMCs, OGG1 as a major 8oxoG repair enzyme in VSMCs, and p300/sirtuin 1 as major regulators of OGG1 through acetylation/deacetylation. Reducing oxidative damage by rescuing OGG1 activity reduces plaque development, indicating the detrimental effects of 8oxoG on VSMC function.

Indexed as

DNA DamageDNA RepairOxidative StressPlaque, AtheroscleroticAcetylationAnimalsAtherosclerosisBiomarkersCells, CulturedDisease Models, AnimalDNA GlycosylasesFemaleGuanineHumansMaleMice, Knockout, ApoE8-hydroxyguanineBiomarkersDNA GlycosylasesGuanineOgg1 protein, mouseOGG1 protein, ratoxoguanine glycosylase 1, humanp300-CBP-Associated Factorp300-CBP Transcription FactorsSIRT1 protein, humanSirt1 protein, mouseSirt1 protein, ratSirtuin 1atherosclerosisDNA damageDNA glycosylasesoxidative stressvascular diseases

Identifiers

PMID29643057
PMCPMC6053042
OpenAlexW2797633816

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.